Galera Therapeutics, Inc.
US ˙ OTCPK ˙ US36338D1081

SecurityGRTX / Galera Therapeutics, Inc.
InstitutionEmerald Bioventures, LLC
Latest Disclosed Ownership61,029,978 shares
Ownership 30.20%
Emerald Bioventures, LLC ownership in GRTX / Galera Therapeutics, Inc.

2026-05-29 - Emerald Bioventures, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 61,029,978 shares of Galera Therapeutics, Inc. (US:GRTX). This represents 30.2 percent ownership of the company. In their previous filing dated 2026-04-27 , Emerald Bioventures, LLC had reported owning 40,216,160 shares, indicating an increase of 51.75 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-05-29 2026-05-29 13D/A 40,216,160 61,029,978 51.75 30.20 13.96
2026-04-27 2026-04-27 13D 40,216,160 26.50
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.